• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS B 123 <4> SYSTEM; BLOOD GAS ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS B 123 <4> SYSTEM; BLOOD GAS ANALYZER Back to Search Results
Catalog Number 05122287001
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/28/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).(b)(4).
 
Event Description
The customer complained of discrepant low results for 1 patient sample tested for potassium (k) on a cobas b 123 instrument compared to a cobas 6000 c (501) module.The k result from the b 123 instrument was 2.99 mmol/l.The k result from the c 501 module was 3.77 mmol/l.No erroneous result was reported outside the laboratory.There was no allegation that an adverse event occurred.The sensor cartridge lot number was 21580192.The expiration date was not provided.
 
Manufacturer Narrative
Based on the data provided, the instrument was calibrated correctly and qc results were acceptable.The sensor in use showed no deviations.The customer compared a whole blood sample on the b 123 instrument to a serum sample tested on the c501 module.These results are not directly comparable due to the methods used.Potassium concentrations will be lower on plasma and whole blood samples than the potassium concentration from a serum sample.Clinically significant pre-analytical issues can occur if the blood samples are not processed expediently.Larger time differences result in higher result differences which is an indication of hemolysis resulting in higher potassium results.In this case, the initial result on the b 123 instrument was performed at 10:03 a.M.And the sample from the c 501 module was processed over 30 minutes later.Depending on how the sample was handled, the elevated potassium result may have been due to hemolysis.A product problem was not found.The b123 instrument and sensor cartridge performed as expected.The investigation was unable to find a definitive root cause.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS B 123 <4> SYSTEM
Type of Device
BLOOD GAS ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7514502
MDR Text Key108374407
Report Number1823260-2018-01502
Device Sequence Number1
Product Code CHL
Combination Product (y/n)N
PMA/PMN Number
K111188
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 05/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05122287001
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 04/30/2018
Initial Date FDA Received05/15/2018
Supplement Dates Manufacturer Received04/30/2018
Supplement Dates FDA Received05/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age44 YR
-
-